FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

INMED PHARMACEUTICALS INC.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2023-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/22aa3d3e-a614-426b-8073-e2831054695b

Reported value

$9.535M{"amount": 9534922, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
INMED PHARMACEUTICALS INC.
Metric
cash_and_equivalents
Period
as of 2023-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001213900-24-013414 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:40:39.452018+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001728328/cash-and-equivalents/2023-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.